NCT06627270 2026-03-05
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Case Comprehensive Cancer Center
Phase 2 Recruiting
Clinical Trials
22 trialsNCT06356597 2026-02-24
Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
Shanghai Jiao Tong University School of Medicine
Phase 2 Active not recruiting
NCT07429760 2026-02-24
Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Phase NA Enrolling by invitation
NCT06616597 2026-02-19
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT06728072 2026-02-09
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Phase 2 Recruiting
NCT04729322 2025-12-23
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06126731 2025-11-24
Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Institute of Cancer Research, United Kingdom
Phase 1/2 Recruiting
NCT06569368 2025-10-06
Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07144657 2025-08-27
GastricMALToma
National Taiwan University Hospital
Phase 2 Not yet recruiting
NCT06793137 2025-01-29
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
AC Camargo Cancer Center
Phase 2 Recruiting
NCT05784311 2024-10-21
SPARROW
Leiden University Medical Center
Phase 4 Recruiting
NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT04312360 2023-09-07
MEFO
Zealand University Hospital
Phase 2 Completed
NCT02682485 2023-04-26
SES-DTA
University of Chicago
Phase 2 Withdrawn
NCT03856671 2023-04-05
Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs
Third Affiliated Hospital, Sun Yat-Sen University
Phase NA Completed
NCT05720559 2023-02-09
Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
Liaoning Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT04264676 2020-11-25
Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT03891979 2020-06-26
Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
NYU Langone Health
Phase 4 Withdrawn
NCT01279252 2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2 Completed
NCT03042091 2018-08-22
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Thomas Jefferson University
Phase EARLY_PHASE1 Unknown
NCT02388581 2016-03-25
First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT00154440 2007-03-26
Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
Technische Universität Dresden
Phase 3 Unknown